As of 2026-01-14, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,637.68 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 13.4x | 12.2x |
| Forward P/E multiples | 12.8x - 39.3x | 25.1x |
| Fair Price | (35.40) - (36.72) | (49.62) |
| Upside | -127.3% - -128.4% | -138.3% |
| Date | EV/EBITDA |